Stephen C. Yang

p53 Mutations and Survival in Stage I Non-Small-Cell Lung Cancer: Results of a Prospective Study

Steven A. Ahrendt, Ying Hu, Marko Buta et al. · JNCI Journal of the National Cancer Institute · 2003 · 223 citations · Full text

Incidence of pulmonary tuberculosis among diabetics

S.J. Kim, Young Pyo Hong, W.J. Lew et al. · Tubercle and Lung Disease · 1995 · 184 citations

Pulmonary Tuberculosis, Diabetes Epidemiology, Tuberculosis Prevention +4

The impact of disease management on outcomes and cost of care: a study of low-income asthma patients.

Louis F. Rossiter, M Y Whitehurst-Cook, Rebecca Small et al. · PubMed · 2000 · 61 citations

Family Medicine, Disease Management, Intervention Community Physicians +16

Induction of lymphokine-activated killer cytotoxicity with interleukin-2 and tumor necrosis factor-? against primary lung cancer targets

Stephen C. Yang, Laurie B. Owen‐Schaub, Elizabeth A. Grimm et al. · Cancer Immunology Immunotherapy · 1989 · 44 citations · Full text

Inflammation, Cytokine, Cancer Immunosurveillance +12

Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.

Stephen C. Yang, Elizabeth A. Grimm, David Parkinson et al. · PubMed · 1991 · 41 citations

Immunology, Immunoediting, Metronomic Chemotherapy +20